Those in the hedge fund industry like Corey Ribotsky will find this article interesting and important. Describing changes in hedge fund owners’ tactics and ways that owners have been looking to capitalize on their success, the article highlights many important changes and opportunities.
Learn more here.
Donors and fundraisers to the Leukemia & Lymphoma Society (LLS) like Corey Ribotsky understand that the more they give and raise, the more research can be done to cure cancers. Recently, two new Marshall A. Lichtman Specialized Center of Research (SCOR) grants were awarded. The SCOR program is LLS’s largest academic research grant. Since it began in 2000, it has had more than $235.
The newest recipients are Frederick W. Alt, Ph.D., Harvard Medical School, and Anthony Green, M.D., Ph.D., University of Cambridge. Each of these grants is valued at $1.25 million a year for five years.
Learn more about this amazing grant and about the most recent recipients.
Live Investment Info